# Screening, Treatment, and Eradication of Hep C

> **NCT05071261** · — · NOT_YET_RECRUITING · sponsor: **Liver Institute PLLC** · enrollment: 112136 (estimated)

## Conditions studied

- Hepatitis C Virus Infection

## Interventions

- **DIAGNOSTIC_TEST:** Hepatitis C Virus Screening

## Key facts

- **NCT ID:** NCT05071261
- **Lead sponsor:** Liver Institute PLLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2030-10-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 112136 (ESTIMATED)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05071261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05071261, "Screening, Treatment, and Eradication of Hep C". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05071261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*